A sandwich-configuration electrochemiluminescence immunoassay based on Cu2O@OMC-Ru nanocrystals and OMC-MoS2 nanocomposites for determination of alpha-fetoprotein

A sandwich-format electrochemiluminescence (ECL) immunosensor has been developed for alpha-fetoprotein (AFP) detection based on the use of ordered mesoporous carbon-molybdenum disulfide (OMC-MoS 2 ) as a sensor platform and cuprous oxide @ ordered mesoporous carbon-Ru(bpy) 3 2+ (Cu 2 O@OMC-Ru) compo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mikrochimica acta (1966) 2021-06, Vol.188 (6), p.213-213, Article 213
Hauptverfasser: Zhang, Ze, Yu, Hongwei, Zhang, Yingcong, Wang, Zhangmin, Gao, Hongmin, Rong, Shengzhong, Meng, Lingqiang, Dai, Jianmin, Pan, Hongzhi, Chang, Dong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A sandwich-format electrochemiluminescence (ECL) immunosensor has been developed for alpha-fetoprotein (AFP) detection based on the use of ordered mesoporous carbon-molybdenum disulfide (OMC-MoS 2 ) as a sensor platform and cuprous oxide @ ordered mesoporous carbon-Ru(bpy) 3 2+ (Cu 2 O@OMC-Ru) composites as signal tags. OMC alongside MoS 2 plays a synergistic role in improving the electrochemical performance of the electrode in the electron transfer process. The uniform cubic-shaped Cu 2 O@OMC-Ru nanocrystals display excellent luminous efficiency, with a signal amplification strategy of OMC-MoS 2 synergistic enhancement and Cu 2 O@OMC which is capable of immobilizing more Ru(bpy) 3 2+ serving as a tracing tag to label antibodies. A detectable ECL emission at a Cu 2 O@OMC-Ru nanocrystals modified electrode is initiated at an applied voltage of +1.15 V (scanning range: 0–1.2 V), in the presence of the tripropylamine (TPA) as coreactant. With the increase in AFP concentration, the loading of Cu 2 O@OMC-Ru at the electrode increases. Afterward, the ECL detection of AFP shows a wide linear range from 0.1 pg/mL to 10 ng/mL with a correlation coefficient of 0.9964 and a detection limit of 0.011 pg/mL (S/ N  = 3) under the optimal experimental conditions. The recoveries were in the range 91.2–97.1% with RSD varying from 4.8 to 8.5%. Overall, the novel immunosensor has been successfully applied to the analysis of human serum samples, indicating a great potential for application in clinical diagnostics. Graphical abstract
ISSN:0026-3672
1436-5073
DOI:10.1007/s00604-021-04848-4